Back to Search
Start Over
Clinical Benefit From a Combination of Brigatinib and Camrelizumab in Sarcomatoid Transformation of ALK-Rearranged Squamous Cell Lung Cancer Resistant to Crizotinib
- Source :
- JTO Clinical and Research Reports, Vol 1, Iss 2, Pp 100009- (2020)
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 26663643
- Volume :
- 1
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- JTO Clinical and Research Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.361266aaef814ab9a3fae8af482b3167
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.jtocrr.2020.100009